ALTUV — Bio-UV SA Cashflow Statement
0.000.00%
- €19.43m
- €40.54m
- €39.58m
Annual cashflow statement for Bio-UV SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.689 | 2.42 | 0.125 | 0.031 | 0.836 |
| Depreciation | |||||
| Non-Cash Items | 0 | — | 0.236 | — | — |
| Unusual Items | |||||
| Changes in Working Capital | -0.367 | -2.61 | 2.48 | 3.56 | 1.01 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.3 | 2.7 | 6.24 | 6.9 | 4.63 |
| Capital Expenditures | -2.73 | -2.22 | -1.96 | -1.94 | -1.64 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -18 | -6.72 | 0.01 | 0.065 | 0.033 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -20.7 | -8.95 | -1.95 | -1.87 | -1.61 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.5 | -2.5 | -3.57 | -3.73 | 3.37 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.73 | -8.82 | 0.731 | 1.39 | 6.3 |